VIA
IGC icon

Vantage Investment Advisors’s IGC Pharma IGC Stock Holding History

Vantage Investment Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,000
Closed -$1K – 847
2014
Q4 		$1K Hold
1,000
– – ﹤0.01% 738
2014
Q3 		$1K Hold
1,000
– – ﹤0.01% 693
2014
Q2 		$1K Buy
+1,000
New +$1.13K ﹤0.01% 680

Other funds holding IGC

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Vantage Investment Advisors's IGC Position: Q1 2015 in Review

Vantage Investment Advisors sold out of IGC Pharma (IGC) in Q1 2015, closing a stake of 1,000 shares — an estimated $1K sold.

Vantage Investment Advisors first reported a position in IGC in Q2 2014 and held it in 3 quarters. The position peaked at $1K in Q4 2014. 5 funds tracked by Wall St. Rank hold IGC as of Q1 2015.

  • Vantage Investment Advisors reported no remaining IGC Pharma position as of Q1 2015 after selling out during the quarter.
  • Vantage Investment Advisors sold 1,000 IGC Pharma shares in Q1 2015, an estimated $1K.
  • Vantage Investment Advisors first reported a position in IGC Pharma in Q2 2014 and held it in 3 quarters.
  • Vantage Investment Advisors's IGC Pharma position peaked at $1K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2015.

Based on Vantage Investment Advisors's 13F filing for Q1 2015, filed 4 May 2015.